Cytotoxic activity of 3-(5-phenyl-3H-[1,2,4]dithiazol-3-yl)chromen-4-ones and 4-oxo-4H-chromene-3-carbothioic acid N-phenylamides

European Journal of Medicinal Chemistry
Tilak RajM P S Ishar

Abstract

6/6,7-Substituted-3-formylchromones (8a-g) were reacted with 2 equivalents thiobenzamide (9) in refluxing toluene to furnish substituted-3-(5-phenyl-3H-[1,2,4]dithiazol-3-yl)chromen-4-ones (10a-g) in high yields. Similarly, when substituted-2-anilino-3-formylchromones (8a-d) were reacted with thiobenzamide (9, 2 equivalents) in refluxing xylene, 4-oxo-4H-chromene-3-carbothioic acid N-phenylamides (11a-d) were obtained in high yields. All the compounds (10a-g) and (11a-d) display significant cytotoxic activity against a number of human cancer cell lines. Among these compounds 10e (IC(50) = 10 microM), 10b (IC(50) = 14.6 microM) and 10a (IC(50) = 10.5 microM) showed maximum cytotoxic activity on neuroblastoma. Also, the compound 10c (IC(50) = 10.5 microM) showed maximum cytotoxic activity on ovarian cancer cell line.

References

Jan 1, 1990·Journal of Natural Products·J M CassadyC J Chang
Jul 4, 1990·Journal of the National Cancer Institute·P SkehanM R Boyd
Mar 1, 1980·Journal of Natural Products·S M KupchanA T Sneden
Mar 4, 2000·Journal of the National Cancer Institute·A M Senderowicz, E A Sausville
Mar 17, 2000·Science·J Drews
Oct 18, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·A MastrolorenzoC T Supuran
Nov 28, 2000·Expert Opinion on Investigational Drugs·L R Kelland
Feb 14, 2003·Current Neurology and Neuroscience Reports·Alyssa T Reddy, Kerry Witek
Apr 8, 2003·Current Medicinal Chemistry. Anti-cancer Agents·Sándor Eckhardt
Apr 24, 2003·Medicinal Research Reviews·Wenying RenLi Zhang
Aug 23, 2003·European Journal of Medicinal Chemistry·B Shivarama HollaBoja Poojary
Mar 12, 2004·Anti-cancer Drugs·Andrea Senff-RibeiroMaria B M Oliveira
Sep 7, 2004·Annals of Neurology·Wojciech RzeskiChrysanthy Ikonomidou
Jan 5, 2005·Nature Reviews. Cancer·Bruce A Chabner, Thomas G Roberts
Jun 29, 2005·Bioorganic & Medicinal Chemistry Letters·Marie-Odile Contour-GalcéraPierre Roubert
Jan 26, 2007·Bioorganic & Medicinal Chemistry·Pei-Liang ZhaoGuang-Fu Yang
Feb 17, 2007·European Journal of Medicinal Chemistry·Roman LesykAndrzej Gzella
May 26, 2007·Bioorganic & Medicinal Chemistry·Wei HuangGuang-Fu Yang
Jun 21, 2007·Journal of Agricultural and Food Chemistry·Pei-Liang ZhaoGuang-Fu Yang
Nov 6, 2007·Current Pharmaceutical Design·B Cvek, Z Dvorak
Nov 16, 2007·Organic & Biomolecular Chemistry·Kazuhito TanabeSei-ichi Nishimoto
Aug 19, 2008·Bioorganic & Medicinal Chemistry Letters·M P S IsharSurinderjit Singh Bhella
May 5, 2009·European Journal of Medicinal Chemistry·Wei HuangGuang-Fu Yang

❮ Previous
Next ❯

Citations

Jan 1, 2010·Acta Crystallographica. Section E, Structure Reports Online·Mohammad AsadHoong-Kun Fun
Jul 15, 2011·Acta Crystallographica. Section E, Structure Reports Online·Mohammad AsadHoong-Kun Fun
Jan 1, 2013·International Journal of Medicinal Chemistry·Balwinder SinghMohan Paul Singh Ishar
Apr 3, 2014·European Journal of Medicinal Chemistry·Rangappa S KeriR Geetha Balakrishna
Nov 28, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yanyang HeMei Zhang
May 14, 2016·The Journal of Organic Chemistry·Bhagyashri D ParmarVivek K Gupta
Apr 9, 2017·Chemical Biology & Drug Design·Edikarlos M BrasilCláudio N Alves
Nov 18, 2015·Chemical Record : an Official Publication of the Chemical Society of Japan ... [et Al.]·Goutam Brahmachari
Oct 13, 2018·Organic & Biomolecular Chemistry·Srinivasarao Yaragorla, Tabassum Khan
Sep 21, 2013·Acta Crystallographica. Section E, Structure Reports Online·P NarayananK Sethusankar
Nov 26, 2015·Acta Crystallographica. Section E, Crystallographic Communications·Rajamani RajaA SubbiahPandi
Jun 6, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Taghreed H El-SayedMohamed Hagar
Jul 16, 2020·Scientific Reports·Fernando Auria-LunaRaquel P Herrera
Sep 24, 2015·Acta Crystallographica. Section E, Crystallographic Communications·Rajamani RajaA SubbiahPandi
Aug 15, 2019·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Jamshed IqbalPeter Langer
Jun 26, 2013·Acta Crystallographica. Section E, Structure Reports Online·P NarayananK Sethusankar
Jan 16, 2014·Acta Crystallographica. Section E, Structure Reports Online·P NarayananK Sethusankar
Sep 24, 2015·Acta Crystallographica. Section E, Crystallographic Communications·Rajamani RajaA SubbiahPandi
Jul 27, 2021·Russian Chemical Bulletin = Izvestii︠a︡ Akademii Nauk. Serii︠a︡ Khimicheskai︠a︡·S S ShatokhinÉ T Oganesyan
Jun 3, 2014·The Journal of Organic Chemistry·Inna Vints, Shlomo Rozen
Feb 22, 2014·Chemical Reviews·Alexandra GasparFernanda Borges

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.